Not yet recruitingOBSERVATIONAL

Risk Factors of Epistaxis Recurrence in Adults

This study is investigating why adults who come to the emergency department with a nosebleed might experience it again. Researchers are looking at the medical records of patients seen between January 2022 and July 2023. They are also contacting some patients to gather more information. The aim is to identify different factors, like age, certain health conditions, or medicines, that might make another nosebleed more likely. By understanding these risk factors, the study hopes to create a tool or 'score' that could predict when a nosebleed might recur within three weeks of the first event. This could help doctors better manage nosebleeds and prevent them from coming back.

At a glance

Status

Not yet recruiting

Sponsor

University Hospital, Grenoble

Enrolment target

145

Start

02 Nov 2024

Estimated completion

01 Apr 2025

Epistaxis

What is this study about?

This study is looking into why some adults who come to the emergency department because of a nosebleed might have another one. We know that nosebleeds can be unsettling, and for some people, they can happen again. This research aims to understand why this happens and what might increase the chances of a nosebleed coming back.

To do this, researchers are carefully reviewing the medical records of adults who visited the emergency department for a nosebleed between January 2022 and July 2023. They are also getting in touch with some of these patients directly to gather more details. The team is looking at a wide range of things, such as whether a person takes certain medications (like blood thinners), if they have conditions like diabetes or high blood pressure, their age, and even if they've had recent surgery or trauma to their nose. They want to see if there's a link between any of these factors and whether a nosebleed recurs.

The main goal of this study is to develop a way to predict who might have another nosebleed within three weeks of the first one. If a nosebleed happens sooner than three weeks, the study considers this a sign that the first bleeding episode wasn't fully controlled. The researchers hope that by creating a 'score' based on the identified risk factors, doctors will have a better tool to understand and manage nosebleeds, potentially preventing them from recurring and helping patients feel more confident after an episode.

Key takeaways

Study explores why nosebleeds recur in adults.
Uses existing emergency department medical records.
Aims to identify risk factors for repeated nosebleeds.
Hopes to create a tool to predict recurrence.
No new treatments or hospital visits required.

Who may be eligible?

This study is looking for adults who attended the emergency department in the hospital involved in the study between January 2022 and July 2023 because they had a nosebleed. To be eligible, you must be 18 years old or older.

You would not be able to be part of this study if you do not wish to be included, or if you aren't able to confirm your willingness to participate. This means your active agreement is needed to be included.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Were you seen in the emergency department for a nosebleed between January 2022 and July 2023?
Are you 18 years old or older?
Did you come to the emergency department for the nosebleed yourself (not just a minor issue)?
Are you willing to have your medical records reviewed for research?
Are you happy to be contacted by phone if needed by the research team?

Answer every question to see your result.

What does participation involve?

If you are eligible and agree to participate, the research team will review your existing medical records from your emergency department visit for a nosebleed. They may also contact you directly by phone to confirm some information related to any recurrence of nosebleeds you might have experienced. There are no special visits, assessments, or medications involved as part of this study. Your participation simply involves the researchers looking at your past medical information and potentially a phone call.

Potential risks and benefits

The potential benefits of participating in this study are that your information could help researchers better understand why nosebleeds come back in some adults. This might lead to improved ways for doctors to predict and manage nosebleeds in the future, ultimately benefiting others. There are very few direct risks to you, as the study mainly involves reviewing existing medical records and a potential phone call. You have the right to withdraw your information from the study at any time, without giving a reason, should you change your mind.

Locations (1)

CHU Grenoble Alpes
Verified postcode
La Tronche, France

Common questions

What is the study trying to find out?

It's trying to understand why some adults who go to the emergency room for a nosebleed have another one, and what factors might make this more likely.

Do I need to take any new medicines?

No, there are no new medicines, treatments, or medical procedures involved with being part of this study.

How will my information be used?

Your medical information will be reviewed by the researchers to identify patterns that might be linked to nosebleeds coming back. It will be kept private and used only for this research.

Will I have to go to extra hospital appointments?

No, participating in this study does not require any additional hospital visits beyond your original emergency department attendance.

What if I change my mind about being in the study?

You are free to withdraw your information from the study at any point, without needing to give a reason.

How to find out more

Ashley BAGUANT, Doctor

abaguant@chu-grenoble.fr +33476764522 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.